edited by Anthony P. DeCaprio
Toxicologic Biomarkers supplies numerous examples, figures, tables, and comprehensive reference listings within each chapter to provide the reader with an in-depth understanding of the subject.
Features:
- Provides approaches for the statistical analysis of biomarker data, and discusses the potential pitfalls associated with these biomarker analyses
- Supplies examples of emerging and exploratory biomarkers for human clinical trials, including QTC, BNP, and KIM-1
- Discusses the validation of new preclinical toxicologic biomarkers with sections on compound selection, analytical and biological reproducibility, and data interpretation
- Compares regulatory agency policy on the use of toxicologic biomarker data, using the U.S. Food and Drug Administration and Environmental Protection Agency as examples
- Contains an overview of current technologies and methods used in the assessment of toxicogenomic and toxicoproteomic biomarkers, and of markers of toxicant susceptibility
- Examines the use of biomarkers of toxicant effect and exposure in environmental and occupational epidemiology studies
- Presents examples and case studies of the use of biomarkers in toxic tort and environmental litigation
Contents
- Introduction to Toxicologic Biomarkers
- Challenges in the Statistical Analysis of Biomarker Data
- Biomarkers of Toxicant Exposure
- Biomarkers in Environmental Epidemiology
- Use of Biomarkers in Health Risk Assessment
- Biomarkers of Toxicant Susceptibility
- Identification and Use of Biomarkers in Preclinical Toxicologic Safety Assessment
- Use of Biomarkers in Clinical Toxicology and Clinical Trials
- Regulatory Guidance and Validation of Toxicologic Biomarkers
- Use of Biomarkers in Occupational Safety and Health
- Toxicogenomic and Toxicoproteomic Approaches for Biomarkers
- Biomarkers of Chemical Warfare Agent Exposure
- Applications of Biomarkers in Toxic Tort and Forensic Litigation
Index